中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2013年
6期
806-807
,共2页
肺疾病,慢性阻塞性%X线摄影术%低剂量
肺疾病,慢性阻塞性%X線攝影術%低劑量
폐질병,만성조새성%X선섭영술%저제량
Pulmonary disease,chronic obstructive%X-Ray%Low dose
目的 探讨数字化(CR)低剂量X线摄影在慢性阻塞性肺疾病(COPD)诊断中的应用.方法 160例COPD患者采用分层随机划分法按照肺功能测试值分为A、B、C、D组各32例,均采用低剂量X线摄影；余32例肺功能轻中度肺气肿患者为E组,进行正常剂量X线摄影作为对照组.统计各组假性正常化例数,并验证肺功能的分级标准.结果 五组假性正常化率差异无统计学意义(x2=4.56,P ＞0.05).结论 CR低剂量X线摄影术对重度及极重度COPD患者的肺气肿检出率较高,中度、轻度COPD检出率极低.
目的 探討數字化(CR)低劑量X線攝影在慢性阻塞性肺疾病(COPD)診斷中的應用.方法 160例COPD患者採用分層隨機劃分法按照肺功能測試值分為A、B、C、D組各32例,均採用低劑量X線攝影；餘32例肺功能輕中度肺氣腫患者為E組,進行正常劑量X線攝影作為對照組.統計各組假性正常化例數,併驗證肺功能的分級標準.結果 五組假性正常化率差異無統計學意義(x2=4.56,P ＞0.05).結論 CR低劑量X線攝影術對重度及極重度COPD患者的肺氣腫檢齣率較高,中度、輕度COPD檢齣率極低.
목적 탐토수자화(CR)저제량X선섭영재만성조새성폐질병(COPD)진단중적응용.방법 160례COPD환자채용분층수궤화분법안조폐공능측시치분위A、B、C、D조각32례,균채용저제량X선섭영；여32례폐공능경중도폐기종환자위E조,진행정상제량X선섭영작위대조조.통계각조가성정상화례수,병험증폐공능적분급표준.결과 오조가성정상화솔차이무통계학의의(x2=4.56,P ＞0.05).결론 CR저제량X선섭영술대중도급겁중도COPD환자적폐기종검출솔교고,중도、경도COPD검출솔겁저.
Objective To investigate the CR low dose radiography to COPD in patients with pseudo normal phenomenon.Methods 160 cases of COPD diagnosed,stratified random dividing method according to the pulmonary function test values were divided into A,B,C and D group.Each group had 32 cases,at the same time,the increase in lung function in patients with mild to moderate pulmonary emphysema in 32 cases was E group,wich was treated with normal dose as a control group,in the normal dose and low dose CR photography failed to clear the diagnosis of emphysema,causing false normalization,statistical the case number,and verify the pulmonary function classification criteria,identify false normalization of lesions in such a case,the general rule to judge the feasibility analysis and prevention.Results There was no significant chifference among 5 groups of pseudo normal comparison (x2 =4.56,P ＞0.05).Conclusion Chronic obstructive pulmonary disease with low dose CR photography on severe and extremely severe patients is deteded by emphysema detection with rate high.Moderate,mild COPD detection rate is extremely low.
